US And EU Systems For Personalized Medicine: Paths Diverging?

There are changes afoot in the regulation and reimbursement policy for IVDs in the EU and US. When it comes to personalized medicine, and companion diagnostics in particular, are the two markets becoming more polarized? Medtech Insight asked US- and EU-based attorneys at Hogan Lovells.

IV1703_Medicine Gets Personal_1200x675

More from In Vitro Diagnostics

More from Diagnostics